Resource Hub

Our podcast

Get tips to empower your learners from conversations with thought leaders in Life Sciences

Most recent

Allison Hunt | Director, Global Curriculum Lead, Advanced Wound Management, Smith+Nephew

Episode 20: The Personalized Learning Journey with Allison Hunt

Episode, September 28, 2023

Listen onThis episode of the Learning Journey Podcast explores the transformative power of personalized learning in the Life Sciences industry. Joined by education expert Allison Hunt, she discusses how tailored learning experiences can boost learner engagement and performance. Allison delves into the importance of aligning training with business goals, leveraging AI technology for personalized learning, and overcoming barriers to adoption.

Listen now

David Noonan

Episode 19: The Gamification Learning Journey with David Noonan

August 28, 2023

Listen now

Michael Eugene

Episode 18: The New Hire Onboarding Journey with Michael Eugene

August 10, 2023

Listen now

Todd Amrhein

Episode 17: The Transformative CL&D Strategies Journey with Todd Amrhein

June 29, 2023

Listen now

Our blogs

Read out blog for the latest topics in Life Sciences learning

Creating Controlled Intelligence: AI Support for Pharmaceutical Field Reps

January 16, 2025

Part 3 – After an extended holiday break, we bring you the final post in our AI Series. Our first blog covered the ABCs of Artificial Intelligence (AI). The second post discussed what pharma executives need to consider to ensure a responsible AI implementation. Today, we go through a use case that can uplift field rep effectiveness and efficiency, while fostering

What Is AI Roleplay for Life Sciences Sales Enablement?

September 1, 2026

Why Traditional Pharma Sales Training Is Failing Field Teams

August 24, 2026

The HCP Engagement Crisis: Why Life Sciences Field Teams Need a New Approach to Readiness

August 19, 2026

Our news

Get the latest news and announcements from ACTO

Industry Report Shows 64% of Life Sciences Leaders Taking Action to Establish AI Governance

Research points to trust as the real barrier to scaling agentic AI, with 58% saying the industry still lacks clear standards for responsible AI TORONTO and NEW YORK — October 28, 2026 — Life sciences organizations are putting governance in place to scale agentic AI across commercial, medical, and patient-facing work, according to the Responsible AI in Life Sciences (RAIL)

ACTO Named a Luminary in Everest Group’s “Innovation Watch: Agentic AI in Life Sciences Commercial 2026”

Recognition highlights ACTO’s role-based SuperAgents, cross-platform orchestration, and Life Sciences-focused approach to governed agentic AI TORONTO and NEW YORK–October 5, 2026 — ACTO, uniting human intelligence with empathetic AI in Life Sciences, today announced that it has been named a Luminary in Everest Group’s Innovation Watch: Agentic AI in Life Sciences Commercial 2026, a global assessment of leading agentic AI